US 9879231
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted A61KA61K2039/5256A61K39/285
Quick answer
US patent 9879231 (Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/5256, A61K39/285, A61P, A61P31/14